Motivation: Alcoholic fatty liver disease (AFLD) and non-AFLD (NAFLD) can progress to severe liver diseases such as steatohepatitis, cirrhosis and cancer. Thus, the detection of early liver disease is essential; however, minimal invasive diagnostic methods in clinical hepatology still lack specificity. Results: Ion molecule reaction mass spectrometry (IMR-MS) was applied to a total of 126 human breath gas samples comprising 91 cases (AFLD, NAFLD and cirrhosis) and 35 healthy controls. A new feature selection modality termed Stacked Feature Ranking (SFR) was developed to identify potential liver disease marker candidates in breath gas samples, relying on the combination of different entropyand correlation-based feature ranking methods including statistical hypothesis testing using a two-level architecture with a suggestion and a decision layer. We benchmarked SFR against four single feature selection methods, a wrapper and a recently described ensemble method, indicating a significantly higher discriminatory ability of up to 10-15% for the SFR selected gas compounds expressed by the area under the ROC curve (AUC) of 0.85-0.95. Using this approach, we were able to identify unexpected breath gas marker candidates in liver disease of high predictive value. A literature study further supports top-ranked markers to be associated with liver disease. We propose SFR as a powerful tool for biomarker search in breath gas and other biological samples using mass spectrometry. Availability: The algorithm SFR and IMR-MS datasets are available under http:/
INTRODUCTION

Clinical background
In the past, the majority of fatty liver diseases (FLD) could be attributed to excessive alcohol consumption. Nowadays, sedentary lifestyle and poor dietary choices, especially in westernized societies, lead to obesity and obesity-associated FLD (Rector et al., 2008) . * To whom correspondence should be addressed.
Depending on this aspect, FLD is clinically divided into two categories: the long-known alcoholic fatty liver disease (AFLD) and the non-AFLD (NAFLD) induced by metabolism-associated causes. Other reasons for NAFLD include parenteral nutrition, gastric bypass surgery and certain disorders of the fatty acid metabolism (Reddy and Rao, 2006) . AFLD and NAFLD can progress to steatohepatitis, cirrhosis and liver cancer. Once progressed to liver cancer, these patients have a very poor prognosis with a 5-year survival rate of <12% (data for USA) (Jemal et al., 2008) .
Blood tests in clinical hepatology are still insensitive and unspecific. While transaminases represent the extent of liver cell damage in the acute setting, there is neither any correlation to the etiology nor to the stage of progression in chronic liver disease. Liver biopsy is invasive and involves pain, the risk of bleeding and bile duct leakage. In addition to these risk factors similar histological features in NAFLD and AFLD make it difficult to distinguish between these two entities (Reddy and Rao, 2006) . Therefore, new non-invasive diagnostic tools in hepatology are urgently needed.
Analysis of volatile compounds in the human breath using mass spectrometry (MS) has been reported to provide useful information on lung cancer (Mazzone, 2008) , diabetes mellitus (Buszewski et al., 2007) or in the estimation of oxidative stress (Risby and Sehnert, 1999) . The liver as the central organ in synthesis and detoxification has great influence on key pathways of metabolism (Tanimizu and Miyajima, 2007) . Liver cell damage leads to altered pathways and the accumulation of metabolites. Many of these accumulated molecules are exhaled, leading to the typical foetor hepaticus, a sweet musty or even slightly faecal aroma arising from liver failure (Mitchell et al., 1999) . The foetor hepaticus that is even detectable for the human nose is the most pronounced form of increased exhalation of volatile substances in liver disease. Sensitive techniques should be able to detect minimal alterations in breath that might occur in earlier stages of liver diseases. Thus, as a non-invasive method, MS analysis of the exhaled breath might be a potential tool for the search of breath gas markers to distinguish between diseased and healthy individuals.
Feature selection for identifying breath gas marker candidates
Modern screening technologies like MS allow to separate and identify small molecules based on their masses. Typical samples are biofluids such as blood, serum or urine, but advances toward higher accuracy and sensitivity have made it possible to analyze also breath gas samples. It can be expected that erroneous metabolic functions are reflected by alterations in the concentration of breath gas molecules. Thus, biomarker discovery as the process of identifying and verifying novel predictors in high-throughput MS data is an important tool in human breath gas research to advance diagnostics, prognostics and disease screening. In general, MS data is characterized by high complexity and dimensionality. A single spectrum consists of several thousands of features expressed as mass over charge. To extract key features that show high discriminatory ability, sophisticated data mining approaches for feature subset selection are required. In general, feature selection methods can be classified into filters, wrappers and embedded and ensemble-based methods, respectively (Osl et al., 2008; Saeys et al., 2007 Saeys et al., , 2008 .
Filter methods rank features based on their quality to discriminate two or more predefined classes (Baumgartner and Graber, 2007) . Examples for filters are the information gain (IG) (Quinlan, 1993) , reliefF (RF) (Hall and Holmes, 2003; Kononenko, 1994) or the biomarker identifier (BMI) (Baumgartner and Baumgartner, 2006) . The IG computes the discriminatory ability of every feature based on an entropy measure. RF is a multivariate correlation-based feature selection method, repeatedly sampling instances, comparing feature values of the k nearest instances for the same and the different classes. A further method, the BMI combines various statistical measures that are the product of sensitivity and specificity, the effect size and variance to calculate an evaluation score for feature ranking.
In contrary, wrappers use machine learning methods to evaluate the discriminatory ability of feature subsets (Inza et al., 2004) , employing heuristic approaches like forward selection to guide the search through the space of possible feature subsets. Well suited to the learning algorithm, feature subsets selected by wrappers are highly discriminatory, but at an extensive computational cost. In contrast, filters are more efficient but less accurate, and prioritize attributes which is particularly important for biological interpretation purposes. Using ensemble techniques, the search for an optimal feature subset in a combined space is basically built into a two-step procedure: (i) creating a set of different feature selectors, and (ii) aggregating the results to a consensus set.
Ensemble methods
It is obvious that a model learned from data includes different types of errors. Thus, the bias-variance decomposition as defined by Geman and authors (1992) distinguishes between three sources of errors: (i) The bias error is a systematic component of the error resulting from differences between the learning method and the domain (Putten et al., 2004) . It is defined as the mean-squared error expected when averaging over models built from all possible training datasets (Witten and Frank, 2005) . (ii) The variance error results from differences between models of different samples. The sum of bias and variance is then called total expected error of a learning method, whilst (iii) the intrinsic error or noise is due to the uncertainty in the domain and cannot be 'learned' (Witten and Frank, 2005) .
One common technique to reduce the bias and variance in a classification task is to combine multiple learning methods ('pooling'). The bias component of the expected error can be reduced by averaging over multiple models built from independent training sets, whilst the variance component can be diminished by combining multiple classifiers. There are different approaches to design ensemble-based learning models.
One approach relies on different resampling techniques to generate multiple models. Using bootstrapping or bagging, a defined number of training datasets are created through randomly drawing subsets with replacement from the initial dataset to build the models (Polikar, 2006) . This ensemble of models is subsequently aggregated to decide about final class prediction. An alternative resampling method is cross validation, in which the data is subdivided into distinct partitions for training and testing. A more sophisticated approach combines different classifiers using a multilayer architecture to reduce the bias. Stacking (Wolpert, 1992) , for example, relies on a two-level structure where the base level or level 0 incorporates different learning algorithms (classifiers) whose predictions serve as input for a level 1 classifier, aggregating level 0 results to the final class prediction. Based on this concept, ensemblebased feature selection methods as recently described by Saeys and authors (2008) propose different strategies for aggregating feature selection results to a consensus ranking, e.g. using the concept of weighted voting or by counting the most frequently selected features to derive the consensus feature subset. It is important to note that for a broad range of applications ensemble methods has been proven to produce favorable results compared with single methods, particularly when dealing with small size datasets (Polikar, 2006 , Saeys et al., 2008 .
In this article, we apply the concept of stacking to feature selection for the identification of breath gas markers in liver disease (AFLD, NAFLD and cirrhosis) using ion molecule reaction-mass spectrometry (IMR-MS) data. The proposed selection method has been designed with objective to readily detect highly generalizing and discriminating feature subsets in small-size datasets (low sample number) by minimizing the method's total expected error. The new feature selection algorithm, termed Stacked Feature Ranking (SFR), utilizes an ensemble-based modality with a stacked learning architecture to construct a consensus feature ranking by combining four single feature selection paradigms in this study, and uses crossvalidation as resampling technique. Our experiments demonstrated that SFR was able to find breath gas marker subsets with high predictive value, greatly exceeding conventional supervised feature selection methods.
EXPERIMENTAL DESIGN
Study subjects
A total of 126 individuals (91 patients and 35 healthy controls) were included in this study for breath gas analysis. The patient cohort was divided into three well-phenotyped subgroups according to a standardized clinical protocol including abdominal ultrasound examinations, laboratory tests and the interpretation of patient history data: the NAFLD cohort (n = 34, mean age 50.9 years), the AFLD cohort (n = 20, mean age 49.5 years) and the liver cirrhosis group (n = 37, mean age 54.8 years). The control cohort (n = 35, mean age 37.4 years) yielded no history of liver disease, showed no serological markers of acute or chronic hepatitis and all blood tests including iron and glucose metabolism were within normal ranges. All 126 samples were obtained from patient breath samples enrolled in the Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Innsbruck, Austria. Clinical protocols were approved by the Innsbruck University Hospital Institutional Review Board, and all individuals gave written informed consent.
Breath sampling
Patients had to fast overnight and were not allowed to use toothpaste within the last hour before the samples were taken. Also smoking was not allowed for the last 20 min and patients had to be at rest for at least 15 min before breath sampling. For breath collection, subjects exhaled once through a standard drinking straw into a small glass vial of 20 ml volume (Macherey-Nagel, Germany). After completing exhalation, the glass vials were crimped airtight with the appropriate crimp cap (Macherey-Nagel, Germany) and transferred for the subsequent MS analysis.
MS analysis
Concentration of 114 volatile compounds in the human exhalation breath was measured using IMR-MS (Airsense, V&F medical development GmbH, Absam, Austria). The necessary ionization process for the detection of sample molecules is performed via ion beams interacting with the gas sample. Mercury with 10.4 eV, xenon with 12.1 eV or krypton with 14.0 eV internal energy are first ionized by electron impact. These primary molecule ions then effect a smooth charge exchange with the breath molecules. This procedure is termed IMR (Hornuss et al., 2007) . It widely avoids the fragmentation of molecules and similarly allows to distinguish between mass identical components, e.g. carbon dioxide and acetaldehyde due to the use of different primary energy levels. After this soft ionization, the breath ions are separated in a quadrupol mass filter and amplified by a conversion dynode. The vials were placed in the V&F autosampler, heated up to 65˚C and dynamically transferred at 90˚C via a 250 µm intermediate polarity deactivated fused silica guard column (Restek corp, CA) to the V&F Airsense. The whole gas transfer from the autosampler to the analyzer lasted 5 min.
The measured gas compounds are given as absolute concentrations (p.p.m. and volume percent for CO 2 and O 2 , respectively). Thirteen of all components were directly calibrated by using calibration gases. The rest of them were indirectly calibrated to the sensitivity of one directly calibrated component. This concept represents a semiquantitative calibration procedure that is widely used in (multicomponent) analytical devices.
Experimental data
We generated a non-invasive and a minimal-invasive dataset including four liver enzymes derived from blood tests. The noninvasive dataset comprises a total of 114 breath gas analytes measured in all individuals enrolled in this biomarker cohort study. The minimal-invasive dataset consists of the same number of gas analytes and measurement values of the four liver enzymes aspartate transaminase (AST), alanine transaminase (ALT), gammaglutamyltransferase (gGT) and alkaline phosphatase (ALP). Both datasets were divided into the four groups as defined above. Formally, a dataset can be described as a set of tuples T , where T ={(c j , m)|c j ∈ C,m ∈ M} with C = {AFLD, NAFLD, cirrhosis, healthy}, where C is the set of class labels and M is the set of features (gas compounds). We examined the following five dichotomous problems for the search for putative breath gas marker candidates, distinguishing between:
• AFLD versus healthy;
• NAFLD versus healthy;
• cirrhosis versus healthy;
• AFLD + NAFLD + cirrhosis versus healthy; and
• AFLD versus NAFLD.
COMPUTATIONAL APPROACH
Data mining workflow
Our proposed feature selection modality is embedded into a fourstep knowledge discovery workflow, including data preprocessing, feature selection and validation and postprocessing (Fig. 1) . We used an in-house developed workflow design tool, termed KD3 (Knowledge Discovery in Database Designer) (Pfeifer et al., 2008) to perform all experiments.
Steps 1 and 2: after data import into the KD3 tool, a common statistical model for outlier detection was applied using the interquartile ranges (IQRs), defining an outlier as observation outside the range [Q 1 − k · IQR;Q 3 + k ·IQR], where Q 1 and Q 3 are the first and third quartiles, IQR is (Q 3 − Q 1 ). The parameter k was set to 3 to remove, by definition, 'strong' outliers in the data. Outlier detection is a crucial task in the knowledge discovery process since outliers can bias and influence the findings, and may lead to incorrect biological interpretations.
Step 3: the preprocessed dataset is then provided for the search for potential biomarker candidates using our new method SFR.
Step 4: significant correlations between breath gas compounds may indicate uncovered and unexpected relations in chemical reactions. Therefore, we searched for inter-correlations of breath gas features using a standard correlation analysis procedure. For normal distributed data, we calculated the Pearson product moment correlation coefficient. For not normally distributed data, we computed the Spearman's rank correlation coefficient, respectively. Only strong correlations with r > 0.8 (P < 0.01) were considered in this analysis. Figure 1 summarizes all computational steps of the breath gas data analysis workflow.
Ensemble-based feature selection algorithm SFR
As expected various feature ranking methods produce different rankings due to the diversity of the underlying statistical models.
The basic idea of SFR is now to use these different ratings as input for an induced meta-level layer that enables to build up an optimized (consensus) feature ranking, exploiting the advantages of an ensemble-based, multilevel design. The basic principle of the algorithm SFR can be described as follows (see also Fig. 2) .
Starting with an empty subset * of features f , we examine at each step the d-highest ranked features (1 < d ≤ m;m is the number of all features), referred to as prediction-input of the given ndifferent level-0 feature ranking methods i . The parameter d is referred to as the depth. In case of d = 2, a set of the two top-ranked features of each single feature ranking method i is selected for the prediction-input (see Fig. 2a ; note that in the figure d = 2 for demonstration purposes only). For this example, the prediction input for the meta level (level 1) is given by the set of features 2, 3, 4, 6 and 9. Next, each single feature f of is added to the featuresubset * and serves as an input for a classifier , calculating the discriminatory ability of the subset expressed by the area under the ROC curve (AUC). That feature that increases best (=f max ) is subsequently added to * , and is stored in a list L,representing the discriminatory ability of the consensus feature subsets. Finally, f max is deleted from all level 0 rankings of i (Fig. 2b) . This procedure is repeated until the feature lists of level 0 rankings is empty (this means that the output set * is filled up with all m features), and the algorithm terminates. To obtain the feature subset showing the highest discriminatory power, the maximal AUC value ( max ) in the list L is determined. The position p in the list L, with p ≤ m, thus defines the feature subset with the best discriminatory ability max . For example, if p = 4, the original m-dimensional feature set is able to be reduced to a subset of four features, indicating highest predictive power in terms of sensitivity, specificity and AUC. The algorithm SFR is boxed below in pseudocode:
Input:
Two-class dataset DS as a set of tuples T c1 and T c2 T c1 := c 1 ,f 1 ,f 2 ,…,f m ; T c2 := c 2 ,f 1 ,f 2 ,…,f m ; Depth d (1 < d ≤ m; m … number of all features); Ψ := Ψ 1 , Ψ 1 ,…, Ψ n ; Output:
Ranked list of marker candidates Σ* := f 1 ,f 2 ,…,f m , Discriminatory ability of each candidate set L := l 1 ,l 2 ,…, l m ; Algorithm: for int l from 1 to n calculate level 0 ranking Ψ n ; for i from 1 to m do for j from 1 to d do for k from 1 to n add j-top ranked feature f j of Ψ k to Π; for each feature f in set Π add f to Σ*; calc Φ(Σ*); // = Φ f remove f from Σ*; add f to Σ* where Φ f = max; // = f max delete f max from Ψ; add Φ(f max ) to L;
SFR Implementation
In the given experimental setup level 0 comprises four popular feature selection methods that are the IG, RF, the BMI (Section 1.2) and a statistical null-hypothesis test using the P-value as measure for discrimination. For hypothesis testing, we applied a two-tailed, two-sample test (Student t-test or Welch test as parametric tests, and the Wilcoxon rank sum test as non-parametric test, respectively). As level 1 classifier, we chose a linear support vector machine (SVM), and determined the AUC to estimate the discriminatory ability of the selected feature subsets (Lasko et al., 2005) .
SVMs constitute a powerful classification method with excellent performance which have become popular in a wide variety of biomedical applications. The idea behind the SVM algorithm can be explained based on four basic concepts: (i) the separating hyperplane; (ii) the maximum margin hyperplane; (ii) the soft margin; and (iv) the kernel function. In principle, a SVM seeks a separating hyperplane in the data that produces the largest separation margin between two classes. Using kernel functions, data vectors are transformed to a higher dimensional space where the separating maximum margin hyperplane can efficiently be determined by solving a constrained quadratic optimization problem (Cristianini and Shawe-Taylor, 2000) .
Statistical validation
Cross-validation was applied to validate the predicted feature rankings. For our experiments, we used a stratified 10-fold crossvalidation strategy in which the dataset is subdivided into 10 roughly equal partitions. The feature selection process is then repeated 10 times, using nine partitions for generating the feature ranking. Therefore, 10 rankings for each partitioning are calculated, and the mean ± SD rank of the selected feature subset is finally denoted.
RESULTS
Predictive power of SFR compared with different feature selection methods
We have developed a new ensemble-based feature selection strategy SFR for searching putative breath gas markers in liver disease, applying the following procedure to identify those feature subsets indicating best discriminatory ability.
(1) Determine a feature ranking for each single feature selection method used in SFR.
(2) Build feature subsets of the k top-ranked consensus features with SFR, and determine the discriminatory ability expressed by the AUC using a SVM classifier.
We evaluated the performance of our method by comparing SFR with the four single feature ranking methods IG, RF, BMI and statistical hypothesis testing (P-value) as well as a wrapper and an ensemble-based feature selection modality that matches SFR best in structure and design. It should be noted that the four single methods also serve as level 0 paradigms in SFR. The wrapper was built on a linear SVM as classifier (in analogy to SFR) and uses a greedy stepwise forward selection strategy for the search through the attribute space. As ensemble feature selector, we chose a paradigm described by Saeys et al., 2008 , performing a linear aggregation of features with respect to their ranks. Figure 3 shows that SFR beats the feature selection methods IG, RF, BMI and hypothesis testing with a 10-15% higher AUC when distinguishing between AFLD and healthy controls. The algorithm selected a subset of five breath gas compounds, achieving the maximal AUC of 0.97 with a sensitivity of 0.95 and an optimal specificity of 1.0. As expected the wrapper method (WR) further improved classification accuracy without exceeding SFR, but at the cost of significantly prolonged computational run time (>7 times). Interestingly, ensemble linear aggregation (ELA) did not greatly improve the single methods in this comparison (but obtained better results in one of the four other experiments, see Table 1 ), which may be explained through SFR's progressive search strategy constrained by stepwise optimizing the discriminatory ability (AUC) of the selected feature subsets, while ELA and other ensemble methods in turn pursue an unconstrained feature aggregation. Table 1 summarizes the mean AUC values for the 5, 10, 20 and 38 (=the first third of all features) top-ranked features obtained for the five dichotomous problems AFLD versus healthy, NAFLD versus healthy, cirrhosis versus healthy, AFLD versus NAFLD and all three diseases versus healthy controls. It should be noted that we used a linear SVM for classification because no improvement was observed when using non-linear kernels (polynomial and radial basis kernels). Interestingly, using a depth of d = 5, SFR achieved the highest AUC in 18 of 20 (90%) subsets. In two comparisons, AFLD versus NAFLD, and cirrhosis versus healthy, BMI and WR, respectively, revealed the maximal AUC (0.85; 0.82) on the top five ranked features.
It is important to note that in 23 of 30 (77%) comparisons SFR outperforms the other six methods with statistical significance for the top 33% selected features. The feature ranking methods signed by '*' denote the different levels of significance for the AUC, Mean AUC values (10-fold cross validated) are denoted for the 5, 10, 20 and 38 (33%) top-ranked features. Significance levels *P < 0.05, **P < 0.01, ***P < 0.001 (Wilcoxon rank sum test) were calculated for the top 33% selected features. Bold numbers indicate maximal AUC values. Statistical hypothesis testing (SHT).
i.e. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with SFR using the Wilcoxon rank sum test. Figure 4a demonstrates the top 10 ranked breath gas marker candidates distinguishing between AFLD and healthy controls. The maximal AUC of 0.97 for AFLD versus controls refers to a subset of five compounds which are acetaldehyde, M103, isoprene, M67 and M60. Note that Mx indicates unannotated compound masses. In this data, the strong correlation (r = 0.86, P < 0.01) found between isoprene and M67 can be explained due to deprotonation. The molar mass of isoprene is 68.11 g/mol, and M67 therefore indicates the correlated deprotonated fragment ion. Further correlations identified, particularly between unannotated pairs of masses, were not able to be interpreted chemically yet, and require further experimental efforts. Figure 4 (b-d) also depict greatly discriminatory ability of selected masses in two comparisons with an AUC > 0.9, and in one with an AUC > 0.85, considering a subset of less than 10 of 114 compounds for best discrimination. A biological interpretation of identified compounds or masses, and their role in liver disease metabolism is still part of our ongoing research.
Identified breath gas markers in liver disease
Using the minimal-invasive dataset including the four invasively measured liver enzymes, the discriminatory ability could be significantly increased when distinguishing between NAFLD + AFLD + cirrhosis versus healthy controls. Figure 5a depicts the discriminatory power of selected compounds including the liver enzymes, Figure 5b without the liver enzymes in the data. Interestingly, combining breath gas and liver enzyme data, a small subset of three compounds, consisting of two enzymes (gGT, AST) and one gas marker (acetaldehyde), could be identified, further increasing the predictive power of an initial model build on the liver enzymes alone (AUC = 0.935 versus 0.944, sensitivity = 0.956 versus 0.945, specificity = 0.914 versus 0.943). For the other dichotomous test problems, the combination of liver enzymes and breath gas compounds yielded no improvement in classification accuracy. It can be seen that SFR is an efficient paradigm to search for highly discriminatory breath gas marker candidates feasible for non-invasive breath gas diagnostics and disease screening. In particular, we were able to develop a combined screening model of high predictive value for three common liver diseases including two established liver enzymes and one breath gas compound that is acetaldehyde, a product of the alcohol dehydrogenase metabolism in the liver, present in all three studied liver diseases.
DISCUSSION AND CONCLUSION
In this work, we have developed SFR, a new ensemble feature selection modality based on the combination of different selection algorithms incorporated into a computational workflow including data preprocessing, breath gas marker search and validation and correlation analysis. SFR uses a two-level learning architecture, exploiting feature rankings from different selection methods in which the decision layer (level 1) decides about the consensus ranking constrained by a strategy optimizing the discriminatory ability of selected features. Embedded into a stratified crossvalidation strategy, SFR effectively reduces bias and variance for the feature subset selection task due to a reamed ensemble-based, multilayer design. Most importantly, SFR is simple to apply since the only parameter that must be specified is the parameter d (depth) to control performance and run time requirements. Our experiments have shown that a depth of d = 5 appeared to be a good trade-off between discriminatory ability and calculation time. One run (=1-fold) takes roughly 8 min on a Intel Centrino 2x-1.83 GHz PC with 2048 MB RAM for selecting the top 33% features in the processed datasets, whilst the wrapper exhibits good experimental results, but has the drawback of extensive computational costs, in this setting of roughly 1 h run time. However, the implementation of additional or alternative feature selection methods in level 0 is expected to lead to a further amplification of this approach in terms of improved discriminatory and predictive power.
As our findings revealed, we were able to identify a set of expected as well as potentially novel breath gas marker candidates in three common liver diseases. It is obvious that a large group of identified masses is still unknown and need further identification in order to understand their physiological and pathophysiological role. However in this study, several breath gas markers that have been associated with liver disease were identified, among these acetaldehyde, found in all three studied liver diseases is the first oxidation product in the ethanol metabolism. It is known to increase lipid peroxidation by generating reactive oxygen species and reactive aldehydes (Niemel, 1999 (Niemel, , 2001 ). In addition to its effects in lipid metabolism, acetaldehyde promotes liver cirrhosis by exerting fibrogenic stimuli to hepatic stellate cells and by upregulating collagen production (Greenwel, 1999) . Isoprene, which is the third top-ranked compound when distinguishing between AFLD and healthy controls, is linked to the cholesterol synthesis as a byproduct derived from mevalonate (Stone et al., 1993) . The effect of circadian rhythm (Taucher et al., 1997) unlikely account for the differences in isoprene levels in our study because all breath samples were taken in the morning. The mass M76 discriminating NAFLD versus AFLD best could tentatively be interpreted as carbon disulphide. Sehnert et al.(2002) , for example, described a triplet of breath gas markers that are carbon disulphide, carbonyl sulphide and isoprene, greatly differentiating between healthy controls and patients with various liver diseases.
In liver cirrhosis, we detected ethanol as putative marker candidate, which may be explained due to the porto-caval shunts, preventing endogenous ethanol (Taucher et al., 1995) to be oxidized in the liver parenchyma, therefore rising the alveolar concentration.
Using our approach, a high predictive, multivariate model for screening for three wide-spread liver diseases could be established. It combines breath gas and liver enzyme data useful for early diagnostics, emphasizing the feasibility and usefulness of SFR for the biomarker search. To evaluate the power of SFR, the method was benchmarked with four single feature selection methods, a wrapper and a recently described ensemble feature selection method. These results obviously demonstrate that SFR greatly increases the discriminatory ability on the selected feature subsets up to 10-15% AUC compared with the examined uni-/multi-variate single and multiple selection methods. The wrapper in turn demonstrates good results in four experiments except the comparison NAFLD + AFLG + cirrhosis versus healthy, but is less practicable because of run time limitations. Furthermore, we were able to verify several breath gas markers from literature, and identified a list of new promising (still unannotated) candidates, underscoring the strength of our method for the search for small subsets of greatly discriminating compounds in complex gas breath samples.
It is important to emphasize that ensemble-based feature selection strategies such as SFR further reduce the methodological bias in small sized datasets by enhancing the discriminatory ability of identified features. Finally, pooling methods further improve the predictive value of identified feature subsets, and therefore we propose SFR as a powerful tool for the search for new and uncovered biomarkers in complex biological mixtures such as breath gas, blood or tissue. Conflict of Interest: none declared.
